foxo4-dri senolytic 2023 2024 study FOXO4-DRI: Human Trial Status, Cancer Research & Data Frontiers | Senolytic Peptide FOXO4-DRI

This type of anemia is caused by a lack of the intrinsic factor needed to support red blood cell production

But what is this miracle all about, and what can it really do for you

BPC-157 appears to support angiogenesis (formation of new blood vessels), which is crucial for nutrient delivery and healing in injured areas

In 2023, the US FDA designated BPC-157 as a Category 2 bulk drug substance, banning it from compounding pharmacies due to insufficient human safety data

Come in for a shot and enhance your day

This intramuscular shot can enhance cognitive function and focus, improve mental clarity and memory, increase energy levels and reduce fatigue, and even support addiction recovery and mood balance